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Abstract
Background: Endothelial nitric oxide synthase (eNOS) is primarily localized on the Golgi apparatus and plasma membrane
caveolae in endothelial cells. Previously, we demonstrated that protein S-nitrosylation occurs preferentially where eNOS is
localized. Thus, in endothelial cells, Golgi proteins are likely to be targets for S-nitrosylation. The aim of this study was to
identify S-nitrosylated Golgi proteins and attribute their S-nitrosylation to eNOS-derived nitric oxide in endothelial cells.
Methods: Golgi membranes were isolated from rat livers. S-nitrosylated Golgi proteins were determined by a modified
biotin-switch assay coupled with mass spectrometry that allows the identification of the S-nitrosylated cysteine residue. The
biotin switch assay followed by Western blot or immunoprecipitation using an S-nitrosocysteine antibody was also
employed to validate S-nitrosylated proteins in endothelial cell lysates.
Results: Seventy-eight potential S-nitrosylated proteins and their target cysteine residues for S-nitrosylation were identified;
9 of them were Golgi-resident or Golgi/endoplasmic reticulum (ER)-associated proteins. Among these 9 proteins, S-
nitrosylation of EMMPRIN and Golgi phosphoprotein 3 (GOLPH3) was verified in endothelial cells. Furthermore, S-
nitrosylation of these proteins was found at the basal levels and increased in response to eNOS stimulation by the calcium
ionophore A23187. Immunofluorescence microscopy and immunoprecipitation showed that EMMPRIN and GOLPH3 are co-
localized with eNOS at the Golgi apparatus in endothelial cells. S-nitrosylation of EMMPRIN was notably increased in the
aorta of cirrhotic rats.
Conclusion: Our data suggest that the selective S-nitrosylation of EMMPRIN and GOLPH3 at the Golgi apparatus in
endothelial cells results from the physical proximity to eNOS-derived nitric oxide.
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Introduction
Nitric oxide (NO) conveys specific cellular signals via S-
nitrosylation despite its highly reactive and diffusible nature
[1,2]. S-nitrosylation is a post-translational modification of
cysteine-thiols to form nitroso-thiols [3]. One of the most
important factors that specify the targets of S-nitrosylation is the
compartmentalization of NO synthase (NOS, a source of NO
N)
with its target proteins for S-nitrosylation [1]. This compartmen-
talization allows for the generation of relatively high local NO
concentrations in the vicinity of the target proteins, which enables
the formation of S-nitrosocysteine. Endothelial NOS (eNOS) is
unique among the NOS family members as it is localized mainly to
specific intracellular membrane domains in endothelial cells,
including the cytoplasmic side of the Golgi apparatus and the
plasma membrane caveolae [4–6].
Previously we showed that the localization of eNOS in the cell is
an important determinant of protein S-nitrosylation [7]. Using a
mutant eNOS that was targeted to the nucleus and wild-type
eNOS that is localized on the Golgi apparatus, we demonstrated
that protein S-nitrosylation occurs where eNOS is localized.
Further, we presented that localization of eNOS at the Golgi
apparatus influences Golgi functions such as protein trafficking in
endothelial cells. Specifically, eNOS localized at the Golgi reduces
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31564the speed of protein transport from the endoplasmic reticulum
(ER) to the Golgi apparatus and from the Golgi to the plasma
membrane [7].
The Golgi is a membrane organelle that plays essential roles in
post-translational modifications such as glycosylation. It is a dynamic
structure and its membranes are constantly remodeled during cell
growth, migration and division. Therefore, eNOS localization to the
Golgi apparatus implies a unique property of this enzyme in
regulating Golgi function, likely through S-nitrosylation of Golgi
membrane proteins [8]. Thus, identification of S-nitrosylated
proteins on the Golgi membranes is required for understanding
endothelial cell function regulated by eNOS-derived NO.
In this study, we performed a proteomic analysis [9] of Golgi
membranes isolated from rat livers and identified 78 putative S-
nitrosylated proteins and the target cysteine residues. Nine of them
were Golgi resident and Golgi/endoplasmic reticulum (ER)-
associated proteins that are largely representative of critical
Golgi-related cellular functions such as protein trafficking and
glycosylation. Among them, we confirmed that at least two
proteins, extracellular matrix metalloproteinase inducer (EMM-
PRIN) and Golgi phosphoprotein 3 (GOLPH3), are endogenously
S-nitrosylated and co-localized with eNOS at the Golgi apparatus
in endothelial cells, providing strong evidence for compartmen-
talization-induced selective S-nitrosylation.
Materials and Methods
Plasmids
A yellow fluorescent protein (YFP)-tagged rat EMMPRIN
cDNA construct was a kind gift from Drs. Andrew P. Halestrap
and Marieangela C. Wilson (University of Bristol, UK) [10]. A red
fluorescent protein (RFP)-tagged wild-type eNOS (WTeNOS-
RFP) was generated as described [7]. An HA-tagged human
GOLPH3 in pBABE-Puro vector was obtained from Addgene
(Cambridge, MA).
Isolation of an enriched Golgi membrane fraction
Rat liver Golgi membranes were isolated from adult male
Sprague-Dawley rats as described [11]. Briefly, male rat livers
were homogenized using a 150-mm mesh sieve in a buffer
containing 100 mM potassium phosphate buffer, pH6.7, 5 mM
magnesium chloride, 0.5 M sucrose and protease inhibitors. The
homogenates were layered over 0.86 M sucrose buffer, followed
by a layer of 0.25 M sucrose buffer, and then centrifuged at
100,0006g for 1 hour at 4uC. After the centrifugation, the Golgi
membrane fraction was accumulated at the interface between
0.5 M and 0.86 M sucrose buffers (Fraction II in Figure 1A). This
Golgi membrane fraction was then adjusted to 0.25 M sucrose,
placed on 0.5 M (middle layer) and 1.3 M sucrose (bottom layer)
buffers, and then centrifuged at 8,0006g for 30 min at 4uC. The
Golgi membrane was collected at the 0.5 M/1.3 M sucrose
interface (Fraction III in Figure 1A).
Quantification of protein S-nitrosylation
S-nitrosocysteine (Cys-NO) formation was determined by tri-
iodide reduction coupled to chemiluminescence detection using a
Sievers 280 NO analyzer as described [9]. Approximately a total
of 400 mg Golgi membrane proteins was used. Golgi membrane
proteins were incubated with different concentrations of NO
donors, Cys-NO and diethylamine NONOate (DEANO), for
10 min at 37uC, and followed by acetone precipitation for 1 hour.
Protein pellets were resuspended in an isolation buffer and
adjusted to a concentration of 1 mg/ml. The isolation buffer
contained 20 mM HEPES, pH7.7, 1 mM diethylene triamine
pentaacetic acid (DTPA), 0.1 mM neocuproine, 1% Triton X-100
and 2 mM methyl methanethiosulfonate (MMTS). Protein
samples were then split into two equal volumes; one sample was
added 1/10 volume of 1% sulfanilamide (SNA)/glacial acid and
incubated on ice for at least 15 min to remove nitrite
contamination. The other sample was added 1/10 volume of
1% SNA/glacial acid and 30 mM HgCl2, incubated at room
temperature (RT) for 10 min, and then placed on ice. S-
nitrosoglutathione (GSNO) was used as a standard. Approximately
15 to 50 mg of Golgi membrane proteins were injected into a
reaction vessel containing 5 ml of 60 mM potassium iodide and
10 mM iodine in glacial acetic acid at 37uC.
Biotin-switch assay
Approximately a total of 2.0 mg Golgi membrane proteins was
used for the biotin-switch assay [12] necessary to perform a
proteomic analysis described below, while an approximately
200 mg of Golgi membrane proteins was used per treatment
group for dose-response and time-course experiments with an NO
donor, S-nitroso-N-acetyl-D,L-penicillamine (SNAP). Golgi mem-
brane proteins were also treated with or without another NO
donor, nitrosocysteine (Cys-NO, 10 mM) for 15 min at 37uC. After
cold acetone precipitation, pellets were resuspended in a lysis
buffer (HEN buffer containing 1%Triton X-100 and protease
inhibitors) to obtain 1 mg/ml. Samples were adjusted to 0.5 mg/
ml containing 2.5% SDS and 200 mM MMTS and incubated at
50uC for 20 min with every 5 min of vortexing to block free thiols.
After blocking, cell extracts were precipitated with two volumes of
220uC acetone, incubated at 220uC for 20 min, centrifuged at
12,0006g for 10 min at 4uC, washed four times with acetone, and
resuspended in 0.2 ml of HENS buffer (25 mM HEPES, pH7.7/
0.1 mM EDTA/0.01 mM neocuproine/1% SDS). Then, 0.4 mM
biotin-HPDP and 5 mM ascorbate were added and incubated at
25uC for 1 hour while rotating. As a control for non-specific
HPDP labeling, ascorbate was omitted. Proteins were precipitated
with acetone. Samples in which protein digestion was performed
for further proteomic analysis were resuspended in 0.45 ml of
0.1 M ammonium bicarbonate and 0.5% SDS [9]. Otherwise,
samples were processed for detection of biotinylated proteins as
previously described [12,13].
Protein digestion and affinity peptide capture
Biotinylated protein samples were incubated with trypsin (1:30
enzyme/protein ratio) at 37uC for 18–24 hours in the dark as
described [9]. The samples were passed through Ultra-free-MC 10-
kDa cutofffiltersthat had previously beenrinsed with methanol and
washed with H2O. The filtrate containing the peptides was
recovered and incubated with approximately 50 ml of dry, washed
streptavidin-agarose beads per mg of initial protein for 30 min with
gentle mixing. The samples were centrifuged at 5,0006g for 5 min,
and the supernatants were discarded. The beads were washed five
times with 10 volumes of 1 M ammonium bicarbonate, followed by
five washes with 10 volumes of deionized water. Between washes,
the samples were centrifuged at 1,0006g for 1 min. An elution
buffer containing 70% formic acid was incubated with the beads for
30 min with gentle mixing. The captured peptides were recovered
by centrifuging the beads at 5,0006g for 4 min and collecting the
supernatants. The captured peptides were evaporated to approx-
imately 5 ml in vacuum, resuspended in 20 ml of 0.1% formic acid,
and desalted using Zip-Tips.
Analysis by LC-MS/MS
Desalted samples were analyzed on a Thermo LTQ linear trap
mass spectrometer equipped with a Thermo micro electrospray
S-Nitrosylation of Golgi Proteins
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Scientific, San Jose, CA) as described [9]. MS/MS spectra were
searched with SEQUEST (Bioworks Browser 3.1 SR1) against the
rat NCBI RefSeq database concatenated with corresponding
reverse sequences. Cysteine modification by MMTS (+46 atomic
mass units) and by biotin-HPDP (+428 atomic mass units) was
specified as variable modifications. Peptide spectrum matches
(PSMs) were empirically filtered by SEQUEST cross correlation
scores (Xc) using PSMs assigned to the reverse database to achieve
an estimated false discovery rate of ,5%. RefSeq accessions were
mapped on to UniProt UniRef accessions.
Immunofluorescence
Transfected COS-7 cells were fixed with 4% paraformaldehyde
in PBS (pH7.4) for 10 min at room temperature (RT) or with cold-
methanol for 10 min at 4uC. After wash, the cells were
permeabilized for 10 min at RT with PBS containing 0.1%
Triton-X 100. The cells were blocked for 30 min at RT with PBS
containing 5% Donkey serum and 1% Bovine serum albumin
(BSA). Afterward, the cells were incubated for 2 hours at RT with
rat anti-HA (1:500; Roche Applied Science, Indianapolis, IN,
Cat#:11867423001) for HA-GOLPH and rabbit anti-eNOS
antibodies (1:10; Novus Biologicals, Littleton, CO, Cat#:NB120-
15280). After wash, the cells were incubated for 1 hour at RT with
secondary antibodies, Alexa Flour 568 anti-rat IgG and Alexa
Flour 647 anti-rabbit IgG (1:500; Invitrogen, Grand Island, NY).
Immuno-labeling of eNOS (rabbit, 1:10; Novus Biologicals,
Littleton, CO, Cat#:NB120-15280), EMMPRIN (goat, 1:100;
Santa Cruz, CA, Cat#:sc-9757), GM130 (mouse, 1:500; BD
Biosciences, CA, Cat#:610822) and GOLPH 3 (rabbit, 1:100;
Abcam, MA, Cat#:AB91492) was performed in bovine aortic
endothelial cells (BAECs) grown in 8-well slides. The cells were
Figure 1. Proteins at the Golgi apparatus can be targets for S-nitrosylation. (A) Golgi membrane enrichment and its purity were assessed
by Western blot with a Golgi marker (GM130), an endoplasmic reticulum (ER) marker (Calnexin) and a nuclear marker (Lamin A/C). Fraction III of the
preparation showed a successful enrichment and purity of Golgi membranes and was used in this study. (B) S-nitrosylated Golgi membrane proteins
were increased dose-dependently in response to the addition of an NO donor, S-nitroso-N-acetylpenicillamine (SNAP). Golgi membranes were treated
with indicated concentrations of SNAP in vitro at room temperature (RM) for 30 min. Protein S-nitrosylation was assessed by the biotin-switch assay.
Asterisks indicate endogenous biotin-containing proteins, thus considered as non-specific bands. Dithiothreitol (DTT), which cleaves nitroso-cysteine
bonds, serves as a negative control. Shown are representative blots from 3 independent experiments. (C) S-nitrosylated Golgi membrane proteins
were increased time-dependently in response to 100 mM SNAP in vitro for indicated incubation times (0, 30 and 60 min). Arrows indicate those
proteins increased in response to SNAP. Asterisks indicate endogenous biotin-containing proteins, thus considered as non-specific bands. Shown are
representative images from 3 independent experiments. (D) The sample quality was verified before performing a proteomic analysis. Successful
biotinylation (i.e., S-nitrosylation) by the biotin-switch assay was determined by Western blot. Golgi membranes were incubated with or without
10 mM S-nitrosocysteine (Cys-NO) for 15 min at 37uC. Then, the biotin-switch assay was performed in the presence or absence of 2 mM ascorbic acid
(AA) (right panel). Proteins were separated by SDS-PAGE and an equal protein loading to each lane was confirmed by Ponceau staining (left panel).
Subsequent Western blotting using an anti-biotin antibody detected biotinylated proteins (right panel). Arrows indicate unique bands of biotinylated
proteins that appeared in the presence of AA. Those biotinylated proteins increased by Cys-NO treatment (the 4
th lane in the right panel) were
identified by mass spectrometry.
doi:10.1371/journal.pone.0031564.g001
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with 0.1% Triton X-100/PBS for 15 min at RT, blocked with 5%
donkey serum/0.3% BSA/PBS for 30 min at RT, and incubated
with primary antibodies overnight at 4uC. Then, the cells were
incubated with secondary antibodies conjugated to 488 or 568
(1:500 in PBS) for 1 hour at RT. After wash, the cells were
mounted with DAPI media (Invitrogen, CA) for nuclear staining
according to the manufacturer’s instruction. Images were taken
using a Nikon E800 Microscope with a Plan-Fluorchromat 406/
0.75 objective (Nikon, Melville, NY).
Immunoprecipitation
Bovine aortic endothelial cells (BAECs) were grown in 15 cm
plates. After overnight serum withdrawal (typically ,16 hours),
the cells were stimulated with 10 mM calcium ionophore (A23187)
for 30 min at 37uC. The cells (,80% confluent) were collected in
1 ml lysis buffer containing 10% glycerol, 50 mM Tris-HCl,
0.1 mM EGTA, 0.1 mM EDTA, 5 mM sodium fluoride, 1 mM
sodium pyrophosphate, 1 mM sodium vanadate, 1 mM 4-(2-
aminoethyl)-benzenesulfonyl fluoride, a protease inhibitor cocktail
tablet (Roche Diagnostics, Mannheim, Germany), 1% (vol/vol)
Nonidet P-40, 0.1% SDS, and 0.1% deoxycholate; pH7.5. Lysates
were incubated for 1 hour at 4uC on a rotating mixer, and
centrifuged at 13,000 rpm for 10 min at 4uC. Approximately
20 ml of Protein G slurry was added to each sample, adjusted to
1 mg protein/500 ml lysis buffer, incubated for 1 hour at 4uC, and
then centrifuged at 11,400 rpm for 20 sec at 4uC to remove non-
specific binding to beads. The supernatants were collected to new
tubes, added 5 ml (1:100) of S-nitrosocysteine antibody (rabbit,
Sigma, St. Louis, MO, Cat#:N5411) [14] or 2 mg of EMMPRIN
antibody (goat, Santa Cruz Biotechnology, Santa Cruz, CA,
Cat#:sc-9757), and then incubated overnight at 4uC on a rotating
mixer. For a negative control, 4 mg of rabbit or goat IgG was used.
Then, ,50 ml of Protein G slurry was added, incubated for 1 hour
at 4uC, and centrifuged at 11,400 rpm for 20 sec at 4uC. Beads
were washed 5 times with 1 ml of washing buffer (0.1 mM EDTA,
0.1 mM EGTA, 50 mM Tris-HCl, pH 7.5). In an additional set of
experiments we included 150 mM NaCl into the wash buffer.
Proteins bound to the antibody were eluted with 50 mlo f2 6SDS
sample buffer containing 2-mercaptoethanol, boiled at 95uC for
10 min, and stored at 280uC until analyzed by Western blot.
Antibodies used for Western blot analysis included rabbit anti-S-
nitrosocysteine (1:1000, Sigma, St. Louis, MO, Cat#:N5411), goat
anti-EMMPRIN (1:500, Santa Cruz Biotechnology, Cat#:sc-
9757), mouse anti- eNOS (1:1000, BD Biosciences, San Jose, CA,
Cat#:610296), and Golgi phosphoprotein 3 (GOLPH3, rabbit,
1:500, Abcam, Cambridge, MA, Cat#:AB91492). Fluorophore-
conjugated secondary antibodies (either 680 nm or 800 nm
emission) were incubated with membranes for 1 hour at RT.
Detection and quantification of bands were performed using the
Odyssey Infrared Imaging System (Li-Cor Biotechnology, Lincoln,
NE).
Generation of cirrhotic rats and isolation of the aorta
from cirrhotic rats
Male Sprague-Dawley rats (Harlan Sprague-Dawley Laborato-
ries, Indianapolis, IN), weighing 100–125 g, were exposed to
carbon tetrachloride (CCl4) by inhalation for 12 weeks as
described [15]. The aorta from three cirrhotic and three age-
matched control rats were used for analysis. Vessels were lysed in
the lysis buffer mentioned above and the biotin switch assay was
performed using an equal amount of proteins (500 mg) per group.
Biotinylated proteins (i.e., S-nitrosylated proteins) were purified
using streptavidin agarose beads and detected by Western blot. All
procedures were performed in accordance with the ‘‘Principles of
Laboratory Animal Care’’ and were approved by the Animal Care
and Use Committee at the Veterans Affairs Healthcare System of
Connecticut (Protocol#: YI0002).
Results
Golgi membrane proteins were successfully enriched
We isolated Golgi membranes from rat livers. We chose this
tissue for several reasons. First, rat liver is the most commonly used
organ for studies of Golgi function and the protocol for isolation of
Golgi membranes is well established [11]. Second, in order to
perform the biotin-switch assay and the subsequent proteomic
analysis, a large quantity of Golgi membrane proteins (at least 1.0–
2.0 mg per treatment) was required.
The yield of Golgi membrane proteins was approximately 1.0–
2.0 mg per liver. An examination of Golgi membrane proteins by
Western blotting showed a successful enrichment of the final Golgi
membrane fraction, which was used for further analysis of S-
nitrosylated Golgi membrane proteins (Figure 1A). There was slight
contamination of endoplasmic reticulum (ER), while contamination
of nuclear membranes was very minimal (Figure 1A).
Golgi membrane proteins are S-nitrosylated in response
to NO donors
To investigate S-nitrosylation of Golgi membrane proteins, we
first determined S-nitrosylated protein levels by the biotin-switch
assay (Figures 1B and C) and the tri-iodide chemiluminescent
method (Figure S1). A dose and time-dependent increase in S-
nitrosylated proteins in response to SNAP treatment of Golgi
membranes was determined (Figures 1B and C). Similarly, S-
nitrosylation of Golgi membrane proteins was increased in
response to treatment with S-nitrosocysteine (Cys-NO) and
DEANO (Figure S1). As reported previously [9], Cys-NO was a
more effective S-nitrosylating agent than DEANO.
Proteomic analysis and identification of S-nitrosylated
Golgi and Golgi/ER-associated proteins
Based on the results in Figure S1 and our previous experience in
exposing cells to different concentrations of Cys-NO [9], we
decided to carry out S-nitrosylation of Golgi membrane proteins
for a proteomic analysis using 10 mM Cys-NO, a concentration
that results in the formation of S-nitrosylated proteins without
compromising cellular functionality [8]. Before conducting a
proteomic analysis, we ran a Western blot after the biotin switch
assay for Golgi membrane proteins to verify whether S-
nitrosylated proteins were biotinylated in the presence or absence
of ascorbic acid (AA) during the biotin-switch assay. In the
presence of AA, nitroso-thiol residues (i.e., S-nitrosylated cysteine
residues) are converted to thiol residues, which then react with
biotin-HPDP, a thiol-specific biotinylating reagent. Therefore,
biotinylation that occurs in the absence of AA can be considered
non-specific. As indicated by arrows in Figure 1D (the 4th lane on
the right membrane), the Cys-NO treatment in the presence of AA
resulted in unique bands of biotinylated (i.e., previously S-
nitrosylated) proteins. Biotinylated proteins were subjected to
tryptic digestion followed by streptavidin-based enrichment of
biotinylated peptides, and subsequent tandem mass spectrometry
analysis. Biotinylated peptides that were identified from samples
treated with biotin-HPDP alone (in the absence of AA) were
considered non-specific and were excluded.
We identified 78 putative S-nitrosylated proteins from our Golgi
membrane samples (Table S1), nine of which were Golgi resident
and Golgi/ER-associated proteins (Table 1), while the rests were
S-Nitrosylation of Golgi Proteins
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proteomic analysis also allowed us to identify the site where S-
nitrosylation occurs on the protein.
EMMPRIN and GOLPH3 are S-nitrosylated in endothelial
cells
Based on availability and specificity of antibodies, we chose two
proteins from Table 1, EMMPRIN (also known as CD147 or
basigin), an inducer of matrix metalloproteinases (MMPs) that are
involved in vascular remodeling [16–18], and Golgi phosphoprotein
3 (GOLPH3), a Golgi-localized oncoprotein implicated in protein
trafficking,receptor recycling, and glycosylation [19], and confirmed
that these proteins are S-nitrosylated in endothelial cells. We
performed the biotin-switch assay coupled with Western blot for
lysates collected from bovine aortic endothelial cells (BAECs) that
were treated with a calcium ionophore, A23187, a well-known
agonist of eNOS activation. Figure 2A shows that EMMPRIN is S-
nitrosylated. Wethen tested whetherEMMPRINisendogenouslyS-
nitrosylated in unstimulated BAECs. For this experiment, we
immunoprecipitatedendothelialcelllysateswithanS-nitrosocysteine
antibody or nonspecific rabbit IgG followed by Western blotting for
EMMPRIN. As shown in Figure 2B (left panel), EMMPRIN was S-
nitrosylated at a detectable level without eNOS stimulation (i.e., at
the basal level) and was increased in response to eNOS stimulation
(Figure 2B, middle and right panels, also see Figure S3).
S-nitrosylation of GOLPH3 was also confirmed in endothelial
cell lysates by the biotin-switch assay (Figure 2C). Like EMM-
PRIN, GOLPH3 was S-nitrosylated at the basal level (without
A23187) and S-nitrosylation of GOLPH3 increased about 3-fold
in response to A23187 treatment in endothelial cells (Figure 2D).
Collectively, these observations suggest that EMMPRIN and
GOLPH3 are S-nitrosylated in endothelial cells at their basal
levels and that S-nitrosylation of these proteins increases upon
eNOS stimulation.
EMMPRIN and GOLPH3 are co-localized with eNOS at the
Golgi apparatus in endothelial cells
First, we determined the cellular localization of EMMPRIN and
GOLPH3 in endothelial cells (Figure 3A). We found that
EMMPRIN was co-localized with eNOS at the Golgi apparatus
(Figure 3A, upper panel). Further, we observed that GOLPH3 was
highly concentrated on the Golgi apparatus (Figure 3A, lower
panel) as indicated by its co-localization with GM130, a Golgi
marker. These results indicate that EMMPRIN and GOLPH3 co-
localize with eNOS at the Golgi apparatus in endothelial cells. In
addition to BAECs, we investigated their cellular localization in
COS cells. We co-expressed eNOS with YFP-tagged EMMPRIN
and HA-tagged GOLPH3 in COS cells. Consistent with our
observation in endothelial cells, our results showed that these three
proteins were co-localized on the Golgi membranes (Figure 3B).
We next examined if these proteins might be physically associated
with each other in endothelial cells. Interestingly, EMMPRIN was
co-immunoprecipitated with both eNOS and GOLPH3 in endo-
thelial cells (Figure 3C, Figure S2). These results suggest that eNOS
interacts with its substrates on the Golgi. EMMPRIN may act as a
scaffold for eNOS and GOLPH3, forming a complex at the Golgi.
EMMPRIN S-nitrosylation is increased in the aorta isolated
from cirrhotic rats
We also examined whether S-nitrosylation of EMMPRIN
increases in pathological conditions where excessive eNOS-
derived NO production is involved. We chose the aorta of
cirrhotic rats with portal hypertension for this purpose, because in
the arteries such as the aorta NO production is increased and
extracellular matrix remodeling occurs [20], a potential role for
EMMPRIN. Furthermore, the aorta provides a relatively large
amount of proteins that are required for the biotin-switch assay to
detect S-nitrosylation, compared to other arteries. EMMPRIN
exists in glycosylated (an active form, 43–66 kDa) and non-
glycosylated forms (,28 kDa). The total EMMPRIN level in the
aorta of cirrhotic rats was approximately 2-fold higher than that of
the normal aorta (Figure 4, left panel). However, as indicated by
Hsp90 content (loading control), the lysates prepared from the
aorta of normal and cirrhotic rats had a similar protein content.
Most interestingly, we found that S-nitrosylated EMMPRIN was
also roughly 2-fold higher in the aorta of cirrhotic rats than that of
normal rats and that glycosylated EMMPRIN was only S-
nitrosylated (Figure 4, right panel).
Table 1. Putative S-nitrosylated Golgi membrane proteins in rats.
Function/protein name
Uniprot
Accession Sequence Residue
Extracellular Matrix Remodeling
1 EMMPRIN/CD147/Basigin P26453 R.SGEYSC#IFLPEPVGR.G 87
Signal Transduction/Golgi Structure
2 Golgi phosphoprotein 3 Q9ERE4 R.QLLDLDPEVEC#LK.A 288
Protein Trafficking
3 ERGIC-53 (p58) Q62902 K.NNPAIVVVGNNGQINYDHQNDGATQALASC#QR.D 190
4 Transmembrane emp24 domain-containing protein 9 (TMED9) Q5I0E7 K.C#FIEEIPDETMVIGNYR.T 28
Glycosylation
5 Alpha-6-fucosyltransferase Q6EV76 R.YATGGWETVFRPVSETC#TDR.S 266
6 Fukutin related protein Q4KLJ4 R.C#DALDGDAVLLMR.S 191
7 Polypeptide N-acetylgalactosaminyltransferase11 Q6P6V1 K.GYVGMAIC#DGSSSQQWR.L 596
8 RCG57892/D-glucuronic acid C5-epimerase D3ZIK0 K.YEEIDC#LINDEHTIR.G 109
Golgi Structure
9 Giantin/MacroGolgin/Rat GCP360(rat) Q63714 R.LKQVQVEIC*ELK.K K.C*REHENNLEGIIK.Q 1399 2267
doi:10.1371/journal.pone.0031564.t001
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Using a mass spectrometry-based approach, we identified for
the first time nine Golgi resident and Golgi/ER-associated
proteins from Golgi membranes isolated from rat livers that are
potential targets for S-nitrosylation. The purity of the isolated
Golgi membranes was reasonable. Although their enriched
fractions showed a low level of ER contamination, it was not
problematic since we identified Golgi/ER-associate proteins as
well as Golgi proteins. Actually, ER contamination is almost
inevitable since many ER resident proteins recycle through the
Golgi where they are recognized by the KDEL receptor and
retrieved back to the ER by COPI vesicles [21]. In fact, some
researchers state that no organelle fractionation technique
produces a ‘‘pure’’ preparation [22].
Importantly, among the nine Golgi resident and Golgi/ER
proteins identified, we validated S-nitrosylation of EMMPRIN
and GOLPH3 in endothelial cells by the biotin-switch assay
coupled with Western blot. In addition, we found that EMMPRIN
and GOLPH3 are basally S-nitrosylated and that S-nitrosylation
of these proteins increases in response to eNOS stimulation. The
immunofluorescence results show that EMMPRIN, GOLPH3 and
eNOS are co-localized at the Golgi apparatus in endothelial cells.
Furthermore, EMMPRIN was co-immunoprecipitated with both
eNOS and GOLPH3, suggesting that these three proteins may
form a complex at the Golgi apparatus. Collectively, these findings
indicate that eNOS-derived NO modulates S-nitrosylation of
EMMPRIN and GOLPH3 in endothelial cells.
eNOS is localized on the cytoplasmic side of the Golgi
apparatus [4–6]. To our knowledge, the membrane topology of
EMMPRIN at the Golgi apparatus is not known. However, given
that glycosylation sites of EMMPRIN are located only on the N-
terminus [16,23], it is likely that the N-terminus is on the luminal
side of the Golgi apparatus, while the C-terminus is on the
Figure 2. EMMPRIN and GOLPH3 are S-nitrosylated in endothelial cells. (A) S-nitrosylation of EMMPRIN was detected by the biotin-switch
assay in bovine aortic endothelial cells (BAECs). Input refers to EMMPRIN levels in lysates before performing the biotin-switch assay. Specificity of
biotinylation was confirmed by incubating samples in the presence or absence of 2 mM ascorbic acid (AA) during the biotin-switch assay. Arrows
indicate S-nitrosylated EMMPRIN (EMP). Shown are representative results from 3 independent experiments. (B) S-nitrosylated EMMPRIN levels in
BAECs in the basal (non-stimulated, left panel) and after eNOS stimulation with 10 mM of a calcium ionophore (A23187) for 30 min to promote NO
production (middle panel). Arrow indicates S-nitrosylated EMMPRIN. BAEC lysates immunoprecipitated (IP) with EMMPRIN (EMP, left panel) or S-
nitroso-cysteine (SNO-cys, middle panel) antibodies were blotted with SNO-cys or EMMPRIN antibodies, respectively. The bar graph on the right panel
shows band intensities of S-nitrosylated EMMPRIN (arrow in the middle panel) in BAECs stimulated with or without A23187. The blots are
representative images from 3 independent experiments. (C) S-nitrosylation of GOLPH3 was detected by the biotin-switch assay in BAECs. Input refers
to GOLPH3 levels in lysates before performing the biotin-switch assay. Specificity of biotinylation was confirmed by incubating samples in the
presence or absence of 2 mM ascorbic acid (AA) during the biotin-switch assay. Arrows indicate S-nitrosylated GOLPH3. The blots are representative
images from 3 independent experiments. (D) S-nitrosylated GOLPH3 levels in BAECs after eNOS stimulation with 10 mM of A23187 for 30 min to
promote NO production (left panel). BAEC lysates immunoprecipitated with S-nitrosocysteine (SNO-cys) antibodies were blotted for GOLPH3. The
graph on the right panel shows band intensities of S-nitrosylated GOLPH3 (arrow in the left panel) in BAECs stimulated with or without A23187.
Shown are representative results from 3 independent experiments.
doi:10.1371/journal.pone.0031564.g002
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nitrosylate the N-terminus of EMMPRIN by diffusing across the
Golgi membrane. GOLPH3 is located on the cytoplasmic surface
of the Golgi apparatus by binding to a membrane lipid,
phosphatidylinositol 4-phosphate [PtdIns(4)P] [19,24,25]. It is
possible that a complex of eNOS, EMMPRIN and GOLPH3 is
formed on the cytoplasmic side of the Golgi apparatus through the
C-terminus of EMMPRIN.
The mass spectrometry-based analysis also identified putative
cysteine residues for S-nitrosylation on these Golgi resident and
Golgi/ER-associated proteins. For example, cysteine 87 of
EMMPRIN is an S-nitrosylated site. This residue is also known
to form a disulfide bond and is located within the extracellular
domain that is also known to induce matrix metalloproteinase 2
(MMP-2) expression/activation [16–18]. Thus, it is possible that
S-nitrosylation of this cysteine residue may influence MMP-2
induction. The functional importance of Cys 288, a site for
GOLPH3 S-nitrosylation identified in this study, has not been
reported. Investigations on the effect of S-nitrosylation on protein
function in relation to its cysteine residue will be highly
appreciated.
EMMPRIN S-nitrosylation may have implication for patholog-
ical vasculature. It is known that the aorta and other arteries of
cirrhotic rats exhibit excessive vasodilation due to elevated eNOS-
derived NO production [26–28]. Further, increased NO level
causes thinning of the aorta in cirrhotic rats, as an NOS inhibitor
ameliorates aortic wall thickness [20]. These observations suggest
that active vascular remodeling takes place in these arteries of
cirrhotic animals and that increased eNOS-derived NO facilitates
such arterial thinning in those animals. Since EMMPRIN is an
inducer of MMPs and could be involved in vascular remodeling,
we examined whether EMMPRIN is S-nitrosylated in the aorta
isolated from cirrhotic rats. Interestingly, EMMPRIN S-nitrosyla-
tion was notably higher in the aorta of cirrhotic rats than that of
normal rats. Importantly, only the glycosylated form of EMM-
PRIN is S-nitrosylated. Given that the Golgi is the major site of
glycosylation and that eNOS is localized on the Golgi, this finding
also supports that the primary site of EMMPRIN S-nitrosylation is
the Golgi apparatus. Although the effect of S-nitrosylation on
EMMPRIN functions is still not clear, it is possible that eNOS-
derived NO enhances S-nitrosylation of mature EMMPRIN,
induces MMP expression/activation and facilitates active arterial
remodeling in cirrhotic animals.
Presently, the selectivity of S-nitrosylation of proteins in vivo is
not completely understood. A recent study by Doulias et al. [29]
has suggested that the selectivity of some proteins requires
secondary structure elements and correct folding. As such
glycosylation of EMMPRIN may be required for correct protein
folding that will facilitate S-nitrosylation.
GOLPH3, also called GPP34, GMx33, MIDAS or yeast
Vps74p, is known to be necessary for protein transport from the
Golgi to the plasma membrane [19]. Using a temperature sensitive
mutant protein, ts045-VSVG-EGFP, we previously demonstrated
that eNOS localized to the Golgi apparatus delays protein
transport from the Golgi apparatus to the plasma membrane,
while a nuclear targeted form of eNOS does not affect the protein
transport [7]. Thus, it is tempting to speculate that S-nitrosylation
of GOLPH3 at the Golgi apparatus by eNOS-derived NO may
Figure 3. EMMPRIN, GOLPH3 and eNOS are co-localized at the
Golgi apparatus in endothelial cells. (A) Immunolabeling of
EMMPRIN, eNOS, GOLPH3 and GM130 (a Golgi marker) in bovine aortic
endothelial cells (BAECs). The upper panel shows EMMPRIN (red, left)
and eNOS (green, center) and their merged image with DNA in blue
(right). Arrows indicate where EMMPRIN and eNOS are located. The
lower panel shows GOLPH3 (red, left), GM130 (green, center), and their
merged image with nucleus in blue (right). Arrows indicate where
GOLPH3 and GM130 are located. Scale bar; 10 mm. Images were taken
using a Nikon E800 Microscope with a Plan-Fluorchromat 406/0.75
objective (Nikon, Melville, NY). Shown are representative images from at
least 3 independent experiments. (B) Immunolabeling of COS cells that
were transfected with wild-type eNOS (blue, upper left panel), YFP-
EMMPRIN (green, upper right panel) and HA-tagged GOLPH3 (red,
lower left panel). The lower right panel shows their merged image.
Scale bar; 10 mm. Arrows indicate eNOS-, EMMPRIN- and GOLPH3-rich
areas. Scale bar; 10 mm. Shown are representative images from at least
3 independent transfection experiments. (C) Immunoprecipitation (IP)
using anti-EMMPRIN (EMP) and total goat IgG from BAEC lysates. IP
samples were blotted with eNOS and GOLPH3 antibodies. Input refers
to eNOS levels in lysates before IP, indicating an equal amount of
proteins in lysates used for IP. The blots are representative images from
three independent experiments.
doi:10.1371/journal.pone.0031564.g003
Figure 4. S-nitrosylation of EMMPRIN is increased in the aorta
isolated from cirrhotic rats. Aorta samples were lysed in a lysis
buffer. Three aorta samples were combined per group to obtain a
sufficient amount of proteins for the biotin-switch assay. Lysates before
the biotin-switch assay were blotted for EMMPRIN and a loading
control, heat shock protein 90 (Hsp90) (input, left panel). Equal amounts
of proteins (500 mg) in the lysates were used for the biotin-switch assay.
Biotinylated proteins were captured by streptavidin agarose beads and
blotted with an EMMPRIN antibody (right panel). The aorta from
cirrhotic rats showed a higher level of S-nitrosylated EMMPRIN than that
of normal rats. Interestingly, only those glycosylated EMMPRIN were S-
nitrosylated in the aorta.
doi:10.1371/journal.pone.0031564.g004
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expressing wild-type eNOS.
The other seven Golgi resident and Golgi/ER-associated
proteins that we identified are also known for their importance in
cellular regulation. ERGIC-53 (also known as p58) and transmem-
brane emp24 domain-containing protein 9 (TMED9) are involved
in protein trafficking between the ER and the Golgi apparatus
[30,31]. ERGIC-53 is an ER-Golgi intermediate compartment
protein and serves as a molecular chaperone for the ER to the Golgi
transport of a specific subset of secreted proteins such as coagulation
factors V and VIII. Its defect causes a combined deficiency of
coagulation factors V and VIII [31]. TMED9 is a member of p24
family [32]. It has been shown that p24 family members play an
important role in retrograde transport from the Golgi to the ER by
facilitating the formation of COPI-coated vesicles [30].
Giantin, a tail-anchored transmembrane protein with a large
(350–380 kDa) N-terminal cytoplasmic region, is known to
regulate Golgi structure. It is localized mostly at the rims of Golgi
cisternae and influences diverse morphological changes of the
Golgi by facilitating COPI vesicle formation and fusion [33,34].
Further, four additional proteins, namely alpha-6-fucosyltransfer-
ase, fukutin related protein, polypeptide N-acetylgalactosaminyl-
transferase II and D-glucuronic acid C5-epimerase, are known to
have implication in protein glycosylation.
As evidence is reported that NO impairs ERGIC-53 transport
from the ER to the Golgi in macrophages [35], it is possible that
these and other functions of these proteins are regulated by S-
nitrosylation. Furthermore, besides the nine Golgi resident and
Golgi/ER-associated proteins, we identified 69 potential S-nitrosy-
lated proteins. They are considered cargo proteins and listed in
Table S1. It is also possible that these cargo proteins are S-
nitrosylated at the Golgi apparatus and distributed to their
designated cellular location, which may subsequently impact the
functions of these proteins. Given that the Golgi is an important site
for post-translational modifications such as phosphorylation, glyco-
sylation and sulfation, it may also be important for S-nitrosylation.
In conclusion, we have identified potential S-nitrosylated Golgi
proteins, which are important regulators of extracellular matrix
remodeling, signal transduction, protein trafficking, glycosylation
and maintenance of the Golgi structure. Importantly, we have
verified S-nitrosylation of EMMPRIN and GOLPH3 in endothelial
cells, two example proteins among those identified. We have also
showed a high prevalence of S-nitrosylated EMMPRIN in the aorta
of cirrhotic rats. These findings provide new insights into organelle
specific S-nitrosylation of proteins regulated by eNOS-derived NO.
Supporting Information
Figure S1 S-nitrosylation of Golgi membrane proteins
is increased in a dose-dependent manner. Tri-iodide
chemiluminescence was used for the measurement of S-nitrosy-
lated proteins formed in response to graded concentrations of NO
donors, S-nitrosocysteine (Cys-NO) and diethylamine nitric oxide
(DEANO).
(TIF)
Figure S2 EMMPRIN forms a complex with eNOS and
GOLPH3 in endothelial cells. Bovine aortic endothelial cell
(BAEC) lysates were immunoprecipitated using an anti-EMM-
PRIN (EMP) antibody or control (Goat) IgG followed by western
blot for indicated proteins. This is a repeat of the experiment
shown in Figure 3C but using a salt-containing wash buffer
(50 mM Tris-HCl, pH7.5, 0.1 mM EDTA/EGTA, and.150 mM
NaCl). EMMPRIN was co- immunoprecipitated with both eNOS
and GOLPH3, although the efficiency was slightly reduced for
eNOS by the addition of 150 mM salt in the wash buffer. This
result confirms our finding in Figure 3C that EMMPRIN forms a
complex with eNOS and GOLPH3 in endothelial cells.
(TIF)
Figure S3 Inhibition of eNOS activity by N(G)-nitro-L-
arginine methyl ester (L-NAME) decreases the forma-
tion of S-nitrosocysteines in endothelial cells. Bovine
aortic endothelial cells (BAECs) were incubated in cell culture
media (Dulbecco’s Modified Eagle’s Media; DMEM) in the
absence of fetal bovine serum (FBS) for 24 hours. Then 100 mM
ATP was added to activate eNOS for 30 min (middle lane). Some
cells were pretreated with 100 mM L-NAME in the absence of
FBS for 24 hours before the addition of ATP (right lane). Cells
were lysed, and 150 mg protein from each sample was analyzed by
SDS-PAGE and western blotting using S-nitrosocysteine (rabbit,
1:500, Sigma, St. Louis, MO, Cat#: N5411) and eNOS (mouse,
1:1000, BD Biosciences, San Jose, CA, Cat#: 610296) antibodies.
Proteins are S-nitrosylated at the base level without L-NAME and
ATP treatment (left lane). The level of S-nitrosylated proteins is
increased by ATP treatment (middle lane) but not when the cells
are pretreated with L-NAME (right lane). Collectively, these
results indicate that the increase in S-nitrosocysteine levels in
BAECs is NOS activity dependent.
(TIF)
Table S1 List of all the putative S-nitrosylated proteins
from Golgi membrane samples. We identified 78 putative S-
nitrosylated proteins from our Golgi membrane samples, nine of
which were Golgi resident and Golgi/ER-associated proteins
(Table 1), while the rests were considered proteins in transit
through the Golgi apparatus. This proteomic analysis also allowed
us to identify the site where S-nitrosylation occurs on the protein.
(XLS)
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